Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and advanced breast cancer: a proof-of-concept trial

Authors: Andrew Tutt, Mark E. Robson, Judy E. Garber, Susan M. Domchek, M. William Audeh, Jeffrey N. Weitzel, Michael Friedländer, Banu Arun, Niklas Loman, Rita K. Schmutzler, Andrew Wardley, Gillian Mitchell, Helena Earl, Mark Wickens, James Carmichael - The Lancet 2010 cited by 1,636